Literature DB >> 15449787

Severe community-acquired pneumonia and sepsis caused by Burkholderia pseudomallei associated with flooding in Puerto Rico.

Bernard Christenson1, Zelma Fuxench, Jose A Morales, Ramón A Suárez-Villamil, Luz M Souchet.   

Abstract

Burkholderia pseudomallei (melioidosis) is usually found in endemic areas of Southeast Asia and Northern Australia. However, a few cases of confirmed melioidosis indigenous to Puerto Rico and the Americas have been reported previously. We describe the occurrence of a B. pseudomallei infection in a female with insulin-dependent diabetes mellitus exposed to flood waters in Puerto Rico. We conclude that B. pseudomallei should be considered a potential pathogen in high-risk patients with severe community-acquired pneumonia and sepsis in Puerto Rico especially in individuals exposed to flood waters during rainy seasons. A more thorough epidemiologic and microbiologic surveillance with environmental sampling may be warranted in the island.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15449787

Source DB:  PubMed          Journal:  Bol Asoc Med P R        ISSN: 0004-4849


  14 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Vidhya Novem; Guanghou Shui; Dongling Wang; Anne K Bendt; Siew Hoon Sim; Yichun Liu; Tuck Weng Thong; Suppiah Paramalingam Sivalingam; Eng Eong Ooi; Markus R Wenk; Gladys Tan
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

4.  Melioidosis is in the Americas: A Call to Action for Diagnosing and Treating the Disease.

Authors:  Alfredo G Torres; Franco E Montufar; Jay E Gee; Alex R Hoffmaster; Mindy G Elrod; Carolina Duarte-Valderrama; Monica G Huertas; David D Blaney
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

Review 5.  Infectious Diseases After Hydrologic Disasters.

Authors:  Stephen Y Liang; Nicole Messenger
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

6.  Melioidosis, northeastern Brazil.

Authors:  Dionne Bezerra Rolim; Dina Cortez Feitosa Lima Vilar; Anastacio Queiroz Sousa; Iracema Sampaio Miralles; Diana Carmen Almeida de Oliveira; Gerry Harnett; Lyn O'Reilly; Kay Howard; Ian Sampson; Timothy J J Inglis
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

7.  Endemic melioidosis in residents of desert region after atypically intense rainfall in central Australia, 2011.

Authors:  Teem-Wing Yip; Saliya Hewagama; Mark Mayo; Erin P Price; Derek S Sarovich; Ivan Bastian; Robert W Baird; Brian G Spratt; Bart J Currie
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

8.  Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.

Authors:  Shane Massey; Linsey A Yeager; Carla A Blumentritt; Sudhamathi Vijayakumar; Elena Sbrana; Johnny W Peterson; Trevor Brasel; James W LeDuc; Janice J Endsley; Alfredo G Torres
Journal:  Sci Rep       Date:  2014-03-07       Impact factor: 4.379

9.  Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing.

Authors:  Axel Karger; Rüdiger Stock; Mario Ziller; Mandy C Elschner; Barbara Bettin; Falk Melzer; Thomas Maier; Markus Kostrzewa; Holger C Scholz; Heinrich Neubauer; Herbert Tomaso
Journal:  BMC Microbiol       Date:  2012-10-10       Impact factor: 3.605

10.  Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.

Authors:  Michael E Woodman; Randall G Worth; R Mark Wooten
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.